Navigation Links
Telomerase Presentations at the AACR 2007 Annual Meeting

of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials. Geron is also the world leader in the development of human embryonic stem cell-based therapeutics, with its spinal cord injury treatment anticipated to be the first product to enter clinical development. For more information, visit www.geron.com.

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Geron's telomerase technology constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Geron's periodic reports, including the annual report on Form 10-K for the year ended December 31, 2006.

Contact

Noonan Russo
David Schull, 858-717-2310 (Media)
david.schull@eurorscg.com
Matthew Haines, 212-845-4235 (Investors)
matthew.haines@eurorscg.com
or
Geron
David L. Greenwood, Chief Financial Officer, 650-473-7765
info@ger
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
2. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. Inspire Announces Presentations at Two European Scientific Conferences
8. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
9. IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting
10. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
11. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Telomerase Presentations the AACR Annual Meeting
(Date:5/23/2013)... --  BioLife Solutions , Inc. (OTC:BLFS), a leading developer, ... storage and cryopreservation freeze media for ... , today announced its participation at the Terrapinn ... this week in London . ... J. Mathew, BioLife,s Senior Vice President and Chief Technology ...
(Date:5/23/2013)... Switzerland and DRESDEN, ... -- Cenix BioScience, a leading preclinical ... RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm ... companies with a focus on the development of ... oncology and companion diagnostics, today announced that they ...
(Date:5/22/2013)... Calif. , May 22, 2013 Advanced ... a medical device that will help alleviate the high ... targeted apheresis cartridge is expected to be the first ... cause of maternal and fetal death. Every ... the United States . It is characterized ...
Breaking Medicine Technology:BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... and AMSTERDAM, December 13 ,Dr. Michael Knauer from ... substantial group of traditionally miscategorized low risk HER2+,patients. ... was used to differentiate between patients at high ... HER2+ patients are commonly identified ...
... December 12 ,Agendia, a world leader in molecular ... to neoadjuvant chemotherapy in,breast cancer. , ... Veer, from the Netherlands Cancer Institute, presented,the data ... (SABCS) during the,session Molecular profiling for guiding therapeutic ...
Cached Medicine Technology:Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients 2Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients 3Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer 2
(Date:5/23/2013)... 2013 Sharon Kleyne and Bio Logic ... product to supplement natural tear film water due to ... Nature’s Tears® EyeMist®, according to Kleyne, is the “first ... fresh water mist to the air around the eyes, ... describes herself as “educator, inventor, radio commentator and water ...
(Date:5/23/2013)... May 23, 2013 With crowded gyms, ... popular. But according to Mike Whitfield, a bodyweight expert ... equipment like the medicine ball can add a whole ... runs BodyweightTorch.com, a website in which anyone can download ... no equipment. Recently, he shared a video with his ...
(Date:5/23/2013)... D.C. (PRWEB) May 23, 2013 Studies show ... more times per week are less likely to be overweight, ... alcohol, perform better academically, and have better relationships with their ... is in danger, according to family dinner expert and advocate ... dinners have declined by 33 percent. When families do eat ...
(Date:5/23/2013)... May 23, 2013 Dr. Garber's ... condition specific remedies are now available at Whole Foods ... CA 92677. The line of natural biotherapy formulas continues ... Chain. , Represented by Brandstorm HBC (Los Angeles, CA), ... Markets throughout California, Nevada and Arizona, as well as ...
(Date:5/23/2013)... 23, 2013 Brad Schmett, Broker Associate ... the already sizzling Palm Springs area real estate ... the immense popularity of the Annual Memorial Day Flower ... May 27, 2013. , Culminating the festive three-day weekend, ... and events along with flight exhibitions. However, the highlight ...
Breaking Medicine News(10 mins):Health News:Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier 2Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2
... , ... firm Jackson & Coker ranked #3 on SIA’s 2009 list of “Ten Best Staffing ... , ... December 11, 2009 -- Each year, Staffing Industry Analysts, a premier research and analysts ...
... The Phoenix Business Journal and BestCompaniesAZ, co-founders ... SCAN Health Plan Arizona has been named to the 2009 ... employees, who provided extensive insight into employee life. , SCAN ... culture and work environment that fosters personal and professional growth ...
... estrogen-positive tumors, study found , THURSDAY, Dec. 10 ... tamoxifen can boost survival in postmenopausal women with ... as estrogen receptor-positive, and it,s best given before ... study. , "Chemotherapy with Adriamycin adds to your ...
... , U.S. Rep. Gerry Connolly (D-Va.) Also to ... 10 The Federal Employees Health Benefits Plan (FEHBP) open enrollment period ... (AFGE) "Inside Government" radio program. The show will air on Friday, ... www.federalnewsradio.com and 1500 AM in the ...
... , DETROIT, Dec. 10 African-American political leaders, ... Monday, December 14th to create and implement a ... African-American Community. , "Detroit is leading the nation ... the Rev. Horace Sheffield III, National Board Member and ...
... to prevent recurrence, researchers find , THURSDAY, Dec. 10 ... millions of women to fight osteoporosis also cut the ... a dual role in keeping women healthy. , ... of breast cancer therapy. Our feeling is that bisphosphonates ...
Cached Medicine News:Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:SCAN Health Plan Arizona Named one of Area's Best Places to Work by the Phoenix Business Journal and BestCompaniesAZ, LLC 2Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 2Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 3Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2Health News:Black Community Unites Against HIV/AIDS Epidemic 2Health News:Bone Drugs May Beat Back Breast Cancer 2
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... two groups of flexible lighting products. The ... in three different sizes 5", 10", and ... of the light). These lights are for ... needed., ,The second group of flexible ...
Medicine Products: